The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease
This study is currently recruiting participants.
Verified January 2012 by Rambam Health Care Campus
Sponsor:
Rambam Health Care Campus
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01509898
First received: January 1, 2012
Last updated: January 12, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of this study was to evaluate the effect of a dental water jet on initial peri-implant disease resolution.
| Condition | Intervention | Phase |
|---|---|---|
|
Peri-implantitis |
Device: Water jet |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease |
Resource links provided by NLM:
Further study details as provided by Rambam Health Care Campus:
Primary Outcome Measures:
- Probing depth [ Time Frame: one month ] [ Designated as safety issue: No ]Probing depth around the implant
Secondary Outcome Measures:
- Bleeding on probing [ Time Frame: one month ] [ Designated as safety issue: No ]Bleeding on probing (BOP) around the implant
| Estimated Enrollment: | 40 |
| Study Start Date: | November 2011 |
| Estimated Study Completion Date: | July 2012 |
| Estimated Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: water-Jet
use of water jet for 1 month
|
Device: Water jet
use of water jet for a month
Other Name: silonit water jet
|
Detailed Description:
Peri-implant disease is becoming more frequent during the last decade. Till today, there is no effective evidence-based treatment. The use of water-jet might improve those situations and reduce morbidity and implant loss.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Signed and dated Informed Consent Form.
- Patient suffer from peri- implant disease
- Age Eligible for study: 18 year old and older
- Genders Eligible for study: Both
Exclusion Criteria:
- Patient substantially fails to comply with the study schedule, or treatment program as described in this Protocol.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01509898
Contacts
| Contact: Dr. liran Levin, DMD | +972502062820 | l_levin@rambam.health.gov.il |
Locations
| Israel | |
| Rambam Hospital | Recruiting |
| Haifa, Israel | |
| Contact: Dr. Liran levin, DMD 972 l_levin@rambam.health.gov.il | |
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
| Study Director: | Dr. Liran Levin, DMD | Department of periodontology |
More Information
No publications provided
| Responsible Party: | Rambam Health Care Campus |
| ClinicalTrials.gov Identifier: | NCT01509898 History of Changes |
| Other Study ID Numbers: | 0374-11-RMB |
| Study First Received: | January 1, 2012 |
| Last Updated: | January 12, 2012 |
| Health Authority: | Israel: Ethics Commission |
Additional relevant MeSH terms:
|
Peri-Implantitis Mouth Diseases Stomatognathic Diseases Periodontal Diseases |
ClinicalTrials.gov processed this record on May 16, 2013